126 related articles for article (PubMed ID: 38047577)
1. A Practical Guide to the Use of Upadacitinib in Ulcerative Colitis and Crohn's Disease.
Weiss A; Barnes EL; Bewtra M
Am J Gastroenterol; 2024 Jan; ():. PubMed ID: 38047577
[No Abstract] [Full Text] [Related]
2. Pharmacokinetics of Upadacitinib in Healthy Subjects and Subjects With Rheumatoid Arthritis, Crohn's Disease, Ulcerative Colitis, or Atopic Dermatitis: Population Analyses of Phase 1 and 2 Clinical Trials.
Nader A; Stodtmann S; Friedel A; Mohamed MF; Othman AA
J Clin Pharmacol; 2020 Apr; 60(4):528-539. PubMed ID: 31701537
[TBL] [Abstract][Full Text] [Related]
3. A SPECIAL MEETING REVIEW EDITION: Highlights in Inflammatory Bowel Disease From the 14th Congress of ECCO: A Review of Selected Presentations From the 14th Congress of the European Crohn's and Colitis Organisation (ECCO) • March 6-9, 2019 • Copenhagen, Denmark
Gastroenterol Hepatol (N Y); 2019 May; 15(5 Suppl 2):1-24. PubMed ID: 31632213
[No Abstract] [Full Text] [Related]
4. Upadacitinib Is Safe and Effective for Crohn's Disease: Real-World Data from a Tertiary Center.
Traboulsi C; Ayoub F; Silfen A; Rodriguez TG; Rubin DT
Dig Dis Sci; 2023 Feb; 68(2):385-388. PubMed ID: 35695972
[TBL] [Abstract][Full Text] [Related]
5. [Compared azathioprine efficacy in ulcerative colitis and in Crohn's disease].
Kull E; Beau P
Gastroenterol Clin Biol; 2002 Apr; 26(4):367-71. PubMed ID: 12070412
[TBL] [Abstract][Full Text] [Related]
6. Indirect costs of inflammatory bowel diseases: Crohn's disease and ulcerative colitis. A systematic review.
Kawalec P
Arch Med Sci; 2016 Apr; 12(2):295-302. PubMed ID: 27186172
[TBL] [Abstract][Full Text] [Related]
7. Association of susceptibility locus for inflammatory bowel disease on chromosome 16 with both ulcerative colitis and Crohn's disease.
Farmer M; Hunt L; Eichenberger MR; Petras RE; Janosky JE; Galandiuk S
Dig Dis Sci; 2001 Mar; 46(3):632-6. PubMed ID: 11318544
[TBL] [Abstract][Full Text] [Related]
8. Deficiency of invariant NK T cells in Crohn's disease and ulcerative colitis.
Grose RH; Thompson FM; Baxter AG; Pellicci DG; Cummins AG
Dig Dis Sci; 2007 Jun; 52(6):1415-22. PubMed ID: 17420939
[TBL] [Abstract][Full Text] [Related]
9. Clinical features and oncological outcomes of intestinal cancers associated with ulcerative colitis and Crohn's disease.
Noguchi T; Ishihara S; Uchino M; Ikeuchi H; Okabayashi K; Futami K; Tanaka S; Ohge H; Nagahara H; Watanabe K; Itabashi M; Okamoto K; Okita Y; Mizushima T; Mizuuchi Y; Yamada K; Shimada Y; Sato Y; Kimura H; Takahashi K; Hida K; Kinugasa Y; Okuda J; Daito K; Koyama F; Ueno H; Yamamoto T; Hanai T; Maemoto A; Oba K; Ajioka Y; Sugihara K;
J Gastroenterol; 2023 Jan; 58(1):14-24. PubMed ID: 36182971
[TBL] [Abstract][Full Text] [Related]
10. Clinical features of ulcerative colitis and Crohn's disease in Turkey.
Ozin Y; Kilic MZ; Nadir I; Cakal B; Disibeyaz S; Arhan M; Dagli U; Tunc B; Ulker A; Sahin B
J Gastrointestin Liver Dis; 2009 Jun; 18(2):157-62. PubMed ID: 19565044
[TBL] [Abstract][Full Text] [Related]
11. Anergy to dinitrochlorobenzene and depression of T-lymphocytes in Crohn's disease and ulcerative colitis.
Meyers S; Sacher DB; Taub RN; Janowitz HD
Gut; 1976 Nov; 17(11):911-5. PubMed ID: 1087263
[TBL] [Abstract][Full Text] [Related]
12. Sequelae of colectomy and ileostomy: comparison between Crohn's colitis and ulcerative colitis.
Steinberg DM; Allan RN; Brooke BN; Cooke WT; Williams JA
Gastroenterology; 1975 Jan; 68(1):33-9. PubMed ID: 1116664
[TBL] [Abstract][Full Text] [Related]
13. Crohn's Disease is a Greater Risk Factor for Nonalcoholic Fatty Liver Disease Compared to Ulcerative Colitis: A Systematic Review.
Kodali A; Okoye C; Klein D; Mohamoud I; Olanisa OO; Parab P; Chaudhary P; Mukhtar S; Moradi A; Hamid P
Cureus; 2023 Aug; 15(8):e42995. PubMed ID: 37671212
[TBL] [Abstract][Full Text] [Related]
14. Use of Vedolizumab in Inflammatory Bowel Disease: A Single-Center Experience.
Erdoğan Ç; Yeşil B; Bacaksız F; Arı D; Gökbulut V; Yüksel M; Özderin Özin Y; Kayaçetin E
Turk J Gastroenterol; 2022 Oct; 33(10):831-837. PubMed ID: 35946879
[TBL] [Abstract][Full Text] [Related]
15. Risk of ulcerative colitis and Crohn's disease in smokers lacks causal evidence.
Pedersen KM; Çolak Y; Vedel-Krogh S; Kobylecki CJ; Bojesen SE; Nordestgaard BG
Eur J Epidemiol; 2022 Jul; 37(7):735-745. PubMed ID: 34091767
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of inflammatory bowel disease in the Australian general practice population: A cross-sectional study.
Busingye D; Pollack A; Chidwick K
PLoS One; 2021; 16(5):e0252458. PubMed ID: 34043730
[TBL] [Abstract][Full Text] [Related]
17. Impact of obesity on disease activity and disease outcome in inflammatory bowel disease: Results from the Swiss inflammatory bowel disease cohort.
Greuter T; Porchet F; Braga-Neto MB; Rossel JB; Biedermann L; Schreiner P; Scharl M; Schoepfer AM; Safroneeva E; Straumann A; Rogler G; Vavricka SR
United European Gastroenterol J; 2020 Dec; 8(10):1196-1207. PubMed ID: 33276710
[TBL] [Abstract][Full Text] [Related]
18. INTERACTIONS AMONG INTERLEUKIN-6, C-REACTIVE PROTEIN AND INTERLEUKIN-6 (-174) G/C POLYMORPHISM IN THE PATHOGENESIS OF CROHN'S DISEASE AND ULCERATIVE COLITIS.
Takač B; Mihaljević S; Glavaš-Obrovac L; Kibel A; Suver-Stević M; Canecki-Varžić S; Samardžija M; Rajkovac I; Kovač D; Štefanić M
Acta Clin Croat; 2020 Mar; 59(1):67-80. PubMed ID: 32724277
[TBL] [Abstract][Full Text] [Related]
19. Redo IPAA After a Failed Pouch In Patients With Crohn's Disease: Is It Worth Trying?
Lavryk OA; Stocchi L; Shawki S; Aiello A; Church JM; Steele SR; Hull TL
Dis Colon Rectum; 2020 Jun; 63(6):823-830. PubMed ID: 32384407
[TBL] [Abstract][Full Text] [Related]
20. Systematic analysis of therapeutic patterns and healthcare use during 12 months before inflammatory bowel disease-related hospitalization in Switzerland.
Schoepfer A; Vavricka SR; Brüngger B; Blozik E; Bähler C
Eur J Gastroenterol Hepatol; 2020 Mar; 32(3):350-357. PubMed ID: 31834046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
